• Home
  • Approach To Consun
    Company profile Management team Business Structure
  • Product Center
    Products Introduction Product video Nephrology series Imaging Series Women & Children Series Orthopedics Series Dermatology Series Hepatobiliary Series Gastroenterology Series Tonic Series Other Products
  • R&D Innovation
    R&D Platform R&D Team R&D Technology R&D Achievements
  • Investor Relations
    Corporate Governance Announcements & Circulars Regular Reports Documents available for inspection IR Contact
  • 中文
Investor Relations
  • Corporate Governance
  • Announcements & Circulars
  • Regular Reports
  • Documents available for inspection
  • IR Contact

Announcements & Circulars

  • 2024-09-02 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 Aug 2024
  • 2024-08-22 CHANGE OF COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE
  • 2024-08-21 Interim Dividend for the six months ended 30 June 2024
  • 2024-08-21 INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2024
  • 2024-08-07 Voluntary Announcement Drug Registration Approval for Iopromide Injection
  • 2024-08-05 NOTICE OF BOARD MEETING
  • 2024-07-31 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
  • 2024-07-18 Voluntary Announcement - (1) Notice of Approval for Clinical Trial of Drug for SK-08 Tablet and (2) Drug Registration Approval for Iodixanol Injection
  • 2024-07-02 Monthly Return on Movements in Securities for the Month Ended 30 June 2024
  • 2024-06-21 LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
HomePrevious1234567891011...69NextLast
  • Approach To Consun

    • Company profile
    • Management team
    • Business Structure
  • Product Center

    • Products Introduction
    • Product video
    • Nephrology series
    • Imaging Series
    • Women & Children Series
    • Orthopedics Series
    • Dermatology Series
    • Hepatobiliary Series
    • Gastroenterology Series
    • Tonic Series
    • Other Products
  • R&D Innovation

    • R&D Platform
    • R&D Team
    • R&D Technology
    • R&D Achievements
  • Investor Relations

    • Corporate Governance
    • Announcements & Circulars
    • Regular Reports
    • Documents available for inspection
    • IR Contact

400-930-1681

总机:(86)20-82016888

service@chinaconsun.com

71 Dongpeng Avenue, Huangpu District, Guangzhou

  • Consun

  • Health Station

  • Micro mall

工商红盾标志

Friendship Link: State Food and Drug Administration Inner Mongolia Food and Drug Administration Guangdong Food and Drug Administration Guangxi Food and Drug Administration

粤ICP备15001491号Design: uweb